 |
 |
|
Bio-Buzz No.02 / February 2007
IN THIS ISSUE HEADLINE NEWS
HEADLINE NEWS BioApproaches SW main event Technology Transfer and commercialisation - Sponsored by Ashfords Technology transfer and business development Key Focus: Wellcome Trust – Technology Transfer and commercialisation The Wellcome Technology Transfer Division seeks to maximise the impact of research innovations on healthcare by facilitating the development of early-stage projects to a point at which they can be further developed by the market. Technology Transfer works through Wellcome Direct Investments to finance enterprises that will have a global impact on the biotechnology industry. Focus is primarily on early-stage life science companies; however, they also invest selectively in later-stage private companies. The Wellcome Trust typically investments up to £10 million over the life of a company through initial and follow-on financings. At this meeting learn more about how you could develop your innovation opportunities by taking part in seminal talks and workshops on funding opportunites, improved business and IP management… 10.00 Registration - Basic introduction to IP focussing on patents 16.30h Close Contact: Register on-line HERE or talk to Jade Fulbrook-Smith for a brief update T: 0117 9008250 E: jade@bioapproaches.co.uk
INDUSTRY CORNER Funding Technology Development Research Initiative - Call 2 $95M California Research and Innovation Initiative (CRII)Targets Green Energy, Biotech and Nanotech Jobs
The CRII would provide funding to several university-based projects around the state hosting clean energy, biotechnology, and nanotechnology research and commercialization activities. International Trade Opportunities United Kingdom Trade and Investment (UKTI) Opportunities Five nations are funding a $1.5 billion program to encourage drug companies to come up with vaccines to help prevent pneumonia and meningitis, in hopes of saving the lives of at least 5.4 million children More… Mission to Denmark and Sweden - Functional Foods and Nutraceuticals, Where Food Meets Medicine in the 21st Century, 19-21 March 2007 More… China medical devices - Consider the CMEF 2007 Spring. Also launched is the FREE 90 page China Scoping Report More… UKTI is inviting Industrial Biotechnology, Bioenergy and Bioprocessing companies to participate in a mission to the US from 21-24 March 2007. More… Business Opportunities European Council of Bioregions (CEBR)is a network of organisations that support their local biocommunity through direct services including networking, incubation, partnering and cluster promotion. It is the first network of its kind to bring together such organisations and Members work to develop and implement new biotech support activities across Europe. TRANSBIO, European funded project matching Transoceanic Biotechnology Opportunities is a two year project focused on the Biotechnology market. The website contains over 100 biotech related profiles from organisations interested in undertaking joint technology based research. There is a search facility on the site, together with contact details should you wish to enquire further. More.... Bio-Entrepreneur School - A series of monthly newsletters keeping you up to date with the latest developments on the UK's first Bio-Entrepreneur School informs you of a new school being run by QED Consulting in association with BioCity Nottingham. The fully funded school offers 3 days of learning and networking and is designed to encourage and nurture people who aspire to starting and growing a business in the bioscience and biotechnology sector. Please find further information click HERE NEW Flying Start Programme for Social Enterprises in Health - With the support and involvement of the Department of Health is being launched. A Flying Start Programme for Social Entrepreneurs in Health (FSPSEH) for graduates (within 10 years of graduation) who would like to start a business in the health care industry. The programme begins with a three day residential in Preston, Lancashire on 16th - 18th April 2007 and is followed by ongoing mentoring by individuals who have experience in the health care industry and expert support for a full 12 months. Participants may also be eligible for additional business support from the Department of Health through their Pathfinders Programme. For more information please go HERE A DTI Global Watch Mission on Advance Cell & Tissue Therapies to the US September 2006 - A mission Report is now available describing the outcomes of a Global Watch Mission to investigate companies working in the field of advanced cell and tissue therapies in California and makes a number of recommendations for UK policy. The mission specifically focused on the bioprocessing technologies that will be required to translate recent scientific discoveries from academic research into marketable therapies. A copy of the fully report can be accessed online (see side navigation bar) More... Oxford Innovation is pleased to announce that it has merged with SQW – enhancing provision of business support, technology commercialization and economic development services. For more details visit: www.oxin.co.uk and www.sqw.co.uk BioWales2007 conference in Cardiff. This event is FREE OF CHARGE. To register – please go to www.wales.gov.uk/biowales Increase your market coverage- Pharmaceutical Technology Asia Pacific
EDITORIAL By Keith Barfoot – Staplethorne Ltd Tel: 01404 42455 Email: medical@staplethorne.co.ukThe Honiton based company (www.staplethorne.co.uk) is one of our most recent members and was set up in 1996 by Dr Keith Barfoot, a physicist. It consists of technology entrepreneurs who provide consultancy and product development services to clients, as well as developing and marketing their own products. Keith particularly enjoys cross-disciplinary projects. Besides working in the medical device field (e.g. electronic stethoscope, ECG, pulse oximetry, portable EEG, cardiac electrophysiology, etc.,), he also works in security applications. One project currently generating interest is the Crystal Chip optical security ‘tag’ which acts as a non-forgeable label or seal which uniquely identifies each item attached to it. This is being developed by client AlphaFox Systems Ltd (www.alphafoxsystems.com) as an anti-counterfeiting system. The counterfeiting problem is immense in monetary terms (circa US$1trillion pa) and ‘labelling’ counter measures are likely to be costed in terms of US$10’s billions pa. The cost of counterfeiting is estimated at: - 5-8% of world trade is in counterfeit goods, rising at 20% pa. Cost to industry US$600 billion pa. Pharmaceuticals labeling: The counterfeit pharmaceuticals market is expected to be worth US$75 billion by 2010. The investments by pharmaceutical companies in RFID counterfeit reduction measures alone will reach US$2.3 billion by 2011. Clearly, not only is there a cost implication to fake pharmaceuticals, but they are also a potential health hazard. Keith is particularly interested hearing from BioApproaches members who have an interest in this area. Applications of Crystal Chip include other ‘mission critical’ applications where the effects of fakes can be devastating, such as aircraft parts, etc., and broadly include: - Brand protection: ‘designer’ goods, consumer items, pharmaceuticals, software, aircraft & auto spares, medical equipment, Staplethorne Ltd and its clients have won 5 SMART awards and several major joint development and consultancy contracts. To date, four further companies have been set by in collaboration with Keith, two of which are based on university IPR and two from industry. The team’s core skills include physics, electronics, instrumentation software and technical project management including company start-ups. They often work in collaborative multidisciplinary projects with individuals, universities, clinicians, companies, and other networks.
EVENTS LISTINGS Covering Lifesciences (biotechnology) and Medical interests can be found at HERE Contact Us For further information on any of these items, please visit our website: Jade Fulbrook-Smith – BioBuzz Editor
|
|
